immunization

Nov
11

Remdesivir Shows Promise in Largest of Several Clinical Trials

Remdesivir is a drug produced by Gilead Sciences for helping in treating Ebola patients. This antiviral drug has even experimented in the US clinical trials on around 1,063 coronavirus patients. When a patient suffering from the dreaded COVID-19 disease is hospitalized, he/she takes an average of 15 odd days to completely recover. When the same […]

DETAIL